Lin Patrick 4
4 · Processa Pharmaceuticals, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Lin Patrick
Chief Business - Strategy Off
Transactions
- Exercise/Conversion
Common Stock
2025-04-01+14,482→ 43,541 total - Tax Payment
Common Stock
2025-04-01$0.41/sh−4,814$1,983→ 38,727 total
Holdings
- 43,500(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Distribution of vested restricted shares